Acrivon Therapeutics, Inc. had a revenue of 0.00 in the quarter ending Mar 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Acrivon Therapeutics, Inc. had annual revenue of 0.00 with ― growth.